64.90
-2.26
(-3.37%)
At close: January 10 at 5:35:51 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 17 | 12 | 15 | 18 |
Avg. Estimate | 5.18B | 5.45B | 22.56B | 23.15B |
Low Estimate | 3.61B | 5.25B | 21.76B | 22.64B |
High Estimate | 5.51B | 5.89B | 22.85B | 23.78B |
Year Ago Sales | 5.1B | 6.18B | 22.1B | 22.56B |
Sales Growth (year/est) | 1.54% | -11.84% | 2.07% | 2.65% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
4PN.DE | -- | -- | -- | -- |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Maintains | Barclays: Overweight to Overweight | 1/8/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/7/2025 |
Maintains | RBC Capital: Outperform to Outperform | 1/3/2025 |
Maintains | Barclays: Overweight to Overweight | 12/5/2024 |
Upgrade | UBS: Neutral to Buy | 11/13/2024 |
Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 10/28/2024 |